Vertex Pharmaceuticals Stock News

Related Stocks: VMW , FIS , MTCH , VFC , CTAS , VRTX , TSLA , TEAM , BILL , EQIX , ADSK , ABBV , ETSY , FISV , TXG ,

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $209.24, marking a +0.52% move from the previous day.

Related Stocks: MSFT , AMZN , GOOG , FB , AAPL , LLY , AFRM , BILL , TFX , TOST , CRM , MTCH , CI , ANTM , GPN , MXIM , MCD , VRTX , ABT , UNP , ADP ,

Hellman Jordan Management Co. Inc. MA boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 44.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,861 shares of the pharmaceutical companys stock after buying an additional 3,346 shares during the period. Vertex Pharmaceuticals []

Taylor Wealth Management Partners grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 16.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,723 shares of the pharmaceutical companys stock after purchasing an additional 240 shares during the quarter. Taylor Wealth Management []

Wells Fargo & Company began coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX) in a research report sent to investors on Wednesday, PriceTargets.com reports. The brokerage issued an overweight rating and a $270.00 price target on the pharmaceutical companys stock. VRTX has been the topic of a number of other research reports. Piper Sandler downgraded Vertex [] The post Vertex Pharmaceuticals (NASDAQ:VRTX) Earns Overweight Rating from Analysts at Wells Fargo & Company appeared first on ETF Daily News .

These stocks could be just what you need to put in your stocking.

It's still early, but a potential cure for the disease isn't out of the question.

Strs Ohio cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 6.2% in the 3rd quarter, HoldingsChannel reports. The firm owned 112,119 shares of the pharmaceutical companys stock after selling 7,461 shares during the quarter. Strs Ohios holdings in Vertex Pharmaceuticals were worth $20,337,000 as of its most recent filing with the Securities []

Wells Fargo & Company began coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX) in a research note released on Wednesday, Price Targets.com reports. The firm issued an overweight rating and a $270.00 price objective on the pharmaceutical companys stock. Other equities analysts have also recently issued research reports about the company. Royal Bank of Canada lifted []

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have received a consensus rating of Buy from the twenty-three ratings firms that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and fourteen have issued a buy recommendation on the company. The average []

New York State Teachers Retirement System lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 3.8% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 328,526 shares of the pharmaceutical company’s stock after selling 13,108 shares during the quarter. New York State Teachers Retirement […]

The stock price of Vertex Pharmaceuticals stock has seen a rise of 7.5% over the last month, while it is up 11% over the last ten trading days. The recent rise can be attributed to positive results fr

Sales are climbing at these biotech companies -- and more potential products are on the horizon.

The "Halftime Report" traders debate Wells Fargo's bullish call on big pharma